Safety of orally administered, USP-compliant levothyroxine sodium tablets in dogs.

about

Safety of orally administered, USP-compliant levothyroxine sodium tablets in dogs.

Item

http://www.wikidata.org/entity/Q47968782

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Safety of orally administered, USP-compliant levothyroxine sodium tablets in dogs.

@en

Safety of orally administered, USP-compliant levothyroxine sodium tablets in dogs.

@nl

type

Item

label

Safety of orally administered, USP-compliant levothyroxine sodium tablets in dogs.

@en

Safety of orally administered, USP-compliant levothyroxine sodium tablets in dogs.

@nl

prefLabel

Safety of orally administered, USP-compliant levothyroxine sodium tablets in dogs.

@en

Safety of orally administered, USP-compliant levothyroxine sodium tablets in dogs.

@nl

P1476

Safety of orally administered, USP-compliant levothyroxine sodium tablets in dogs.

@en

P2093

J Caldwell

http://www.w3.org/2001/XMLSchema#string

J E Hare

http://www.w3.org/2001/XMLSchema#string

W E Lloyd

http://www.w3.org/2001/XMLSchema#string

P2860

Thymic hyperplasia in patients with Graves' disease. Identification of thyrotropin receptors in human thymus

Prothrombin, activated partial thromboplastin, and proteins induced by vitamin K absence or antagonists clotting times in 20 hyperthyroid cats before and after methimazole treatment.

Thrombocytopenia in Graves' disease: effect of T3 on platelet kinetics.

The renal manifestations of thyroid disease.

Renal sodium- and potassium-activated adenosine triphosphatase and sodium reabsorption in the hypothyroid rat.

The liver in other (nondiabetic) endocrine disorders.

Characterization of the anaemia associated with Graves' disease

Hemostatic abnormalities in endocrine and metabolic disorders.

Thyroid hormones increase Na+-H+ exchange activity in renal brush border membranes

The effect of thyroid disorders on lipid levels and metabolism.

P304

254-265

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JVP.12457

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

C M K Morrow

P577

2017-11-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29139142

http://www.w3.org/2001/XMLSchema#string